Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Versant Venture Capital VI, L.P. Create: Alert

All | News | Filings
Date FiledTypeDescription
02/09/2023 SC 13G/A Versant Venture Capital VI, L.P. reports a 19.4% stake in Century Therapeutics, Inc.
01/13/2023 SC 13D/A Versant Venture Capital VI, L.P. reports a 0% stake in OYSTER POINT PHARMA, INC.
01/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2022 4 Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Century Therapeutics, Inc.
Txns: Sold 550,000 shares @ $13.0302, valued at $7.2M
Disposed of 364,800 shares @ $0
06/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/09/2022 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
05/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2022 SC 13G Versant Venture Capital VI, L.P. reports a 22.6% stake in Century Therapeutics, Inc.
02/10/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/13/2022 SC 13D/A Versant Venture Capital VI, L.P. reports a 8.5% stake in OYSTER POINT PHARMA, INC.
01/07/2022 4 Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns: Disposed of 200,213 shares @ $0
Acquired 51,556 shares @ $0
Disposed of 51,556 shares @ $0
Disposed of 1,261 shares @ $0
12/28/2021 4 Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Century Therapeutics, Inc.
Txns: Disposed of 371,004 shares @ $0
12/23/2021 4 Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns: Disposed of 200,213 shares @ $0
Acquired 51,556 shares @ $0
Disposed of 51,556 shares @ $0
Disposed of 1,261 shares @ $0
10/27/2021 SC 13D/A Versant Venture Capital VI, L.P. reports a 8.6% stake in OYSTER POINT PHARMA, INC.
10/20/2021 4 Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns: Sold 303,614 shares @ $14.6327, valued at $4.4M
Sold 1,912 shares @ $14.6327, valued at $28k
Sold 242,943 shares @ $15.0939, valued at $3.7M
Sold 1,531 shares @ $15.0939, valued at $23.1k
08/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/09/2021 SC 13D Versant Venture Capital VI, L.P. reports a 26.3% stake in Graphite Bio, Inc.
07/08/2021 SC 13D Versant Venture Capital VI, L.P. reports a 15.3% stake in Monte Rosa Therapeutics, Inc.
07/06/2021 3 Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 3 on Tempest Therapeutics, Inc.
07/01/2021 4 Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Graphite Bio, Inc.
Txns: Converted 12,343,727 shares @ $0
Converted 1,527,719 shares @ $0
Bought 180,000 shares @ $17, valued at $3.1M
Converted 30,019,945 preferred shares @ $0
Converted 3,715,415 preferred shares @ $0
06/30/2021 4 Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Monte Rosa Therapeutics, Inc.
Txns: Converted 6,515,869 shares @ $0
Converted 1,940,043 shares @ $0
Bought 157,895 shares @ $19, valued at $3M
Converted 20,004,280 convertible preferred @ $0
Converted 3,000,000 convertible preferred @ $0
Converted 4,150,000 convertible preferred @ $0
Converted 2,699,328 convertible preferred @ $0
06/24/2021 3 Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 3 on Graphite Bio, Inc.
06/23/2021 3 Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 3 on Monte Rosa Therapeutics, Inc.
06/23/2021 4 Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Century Therapeutics, Inc.
Txns: Converted 9,936,011 shares @ $0
Converted 614,095 shares @ $0
Bought 100,000 shares @ $20, valued at $2M
Converted 25,000,000 preferred shares @ $0
Converted 1,545,125 preferred shares @ $0
06/21/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/17/2021 3 Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 3 on Century Therapeutics, Inc.
06/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/03/2021 SC 13D/A Versant Venture Capital VI, L.P. reports a 5.1% stake in Aligos Therapeutics, Inc.
04/08/2021 SC 13D Versant Venture Capital VI, L.P. reports a 13.4% stake in LAVA THERAPEUTICS N.V.
04/05/2021 SC 13D/A Versant Venture Capital VI, L.P. reports a 8.6% stake in OYSTER POINT PHARMA, INC.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy